Akers Biosciences, Inc. (AKER): Consensus Estimates and Trading Data

In the past 52-week period, shares of Akers Biosciences, Inc. (NASDAQ:AKER) have moved within the range of $0.12 to $2.90. On the stock’s most recent trading day, the company’s shares ended the regular session at $0.13, which is 95.52% higher than its 52-week high.

Akers Biosciences, Inc. (AKER) has demonstrated a 20-day simple moving average (SMA) of -59.49%, and a 50-day SMA of -76.71%. This public company’s current market capitalization stands at $1.34 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Akers Biosciences, Inc. (AKER) is Buy.

When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Akers Biosciences, Inc. (AKER) delivered a 56.97% surprise with its net revenue.

Meanwhile, during the same quarter Akers Biosciences, Inc. (AKER) delivered a 0.00% earnings surprise.

Ownership at Akers Biosciences, Inc. (AKER), According to Most Recent SEC Filings

Additionally, according to the most recent 13F filing from Akers Biosciences, Inc. (AKER), there were 2 new positions totaling 24,319 shares of the company’s stock. There were 2 sold out positions, on the other hand, totaling 10,172 shares.

Short, Medium and Long Term Indicators

Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Akers Biosciences, Inc. (AKER) has had a 20-day average volume of 2,464,085 shares, with an average of 60% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 1,142,374 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 685,026 shares with 100% of long-term indicators pointing to Sell.